Skip to main content

Table 1 Relationship between miR-34a expression and clinicopathological features in EHCC patients

From: microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway

Clinicopathological features

n

miR-34a

P value

Low

High

Age (yr)

   

0.695

<60

14

4

10

 

≥60

13

5

8

 

Gender

   

1.000

Male

16

8

8

 

Female

11

6

5

 

Tumor size (cm)

   

0.449

<2

12

5

7

 

≥2

15

9

6

 

Pathological type

   

0.222

Adenocarcinoma

24

11

13

 

Mucocellulare carcinoma

0

0

0

 

Adenosquamous carcinoma

3

3

0

 

Squamous carcinoma

0

0

0

 

Undifferentiated carcinoma

0

0

0

 

Cell differentiation

   

0.326

Well

4

3

1

 

Moderately

8

5

3

 

Poorly

15

8

7

 

Bismuth classification

   

0.385

Bismuth I

7

1

6

 

Bismuth II

13

10

3

 

Bismuth III

6

2

4

 

Bismuth IV

1

1

0

 

Lymphatic node metastasis

   

0.004

Absent

9

1

8

 

Present

18

13

5

 

Clinical stages

   

<0.001

I + II

13

2

11

 

III + IV

14

12

2

 
  1. P <0.05 is significant